CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
13F holders, Q4 2025
Institutional positions in CDT Equity Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −1 vs. Q3 2025
- Shares held
- 32.4K
- +12.3K (+61.3%) vs. Q3 2025Converted for a 1-for-8 split
- Total value
- $41.4K
- −$67.7K (−62.0%) vs. Q3 2025
- New holders
- 2
- 3 more added
- Sold out
- 3
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $94.7K |
| Q1 2026 | 2 | $571 |
| Q4 2025 | 9 | $41.4K |
| Q3 2025 | 10 | $109.2K |
| Q2 2025 | 14 | $56.4K |
| Q1 2025 | 34 | $386.9K |
| Q4 2024 | 42 | $599.0K |
| Q3 2024 | 35 | $479.5K |
| Q2 2024 | 29 | $3.12M |
| Q1 2024 | 18 | $5.91M |
| Q4 2023 | 11 | $6.26M |
| Q3 2023 | 3 | $32.0K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding CDT Equity Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 15,636 | $20.0K | 0.00% | +15,636 | New |
| Apollon Wealth Management, LLC | 13,431 | $17.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Tower Research Capital LLC (TRC) | 2,641 | $3.38K | 0.00% | +2,445+1,244.9% | AddedConverted for a 1-for-8 split |
| UBS Group AG | 635 | $813 | 0.00% | −1,321−67.5% | ReducedConverted for a 1-for-8 split |
| Morgan Stanley | 11 | $14 | 0.00% | +0+1.1% | AddedConverted for a 1-for-8 split |
| Bank of America Corp | 11 | $14 | 0.00% | +8+300.0% | AddedConverted for a 1-for-8 split |
| BlackRock, Inc. | 9 | $12 | 0.00% | −0−2.7% | ReducedConverted for a 1-for-8 split |
| SBI Securities Co., Ltd. | 2 | $3 | 0.00% | −1−20.0% | ReducedConverted for a 1-for-8 split |
| Barclays PLC | 2 | $3 | 0.00% | +2 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −4,451−100.0% | Sold outConverted for a 1-for-8 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −2−100.0% | Sold outConverted for a 1-for-8 split |
| CWM, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold outConverted for a 1-for-8 split |